| Todd A Phillips, MD | |
|
1615 Delaware St, Anesthesia Dept, Longview, WA 98632-2310 | |
| (360) 425-7280 | |
| Not Available |
| Full Name | Todd A Phillips |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1615 Delaware St, Longview, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073597563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD00037091 (Washington) | Primary |
| Entity Name | Longview Anesthesiology Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003894957 PECOS PAC ID: 0749177756 Enrollment ID: O20040303001054 |
News Archive
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
On Monday (Jan. 25, 2016), the World Health Organization announced that Zika virus, a mosquito-borne illness that in the past year has swept quickly throughout equatorial countries, is expected to spread across the Americas and into the United States.
Five years on from September 11, the University of Western Sydney can offer expert comment on how the anniversary is likely to affect those who lost loved ones in the tragedy and how it will impact on people around the world.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 8 days ago
| Entity Name | Providence Health & Service- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508118555 PECOS PAC ID: 0840279758 Enrollment ID: O20090717000201 |
News Archive
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
On Monday (Jan. 25, 2016), the World Health Organization announced that Zika virus, a mosquito-borne illness that in the past year has swept quickly throughout equatorial countries, is expected to spread across the Americas and into the United States.
Five years on from September 11, the University of Western Sydney can offer expert comment on how the anniversary is likely to affect those who lost loved ones in the tragedy and how it will impact on people around the world.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 8 days ago
| Entity Name | Narrows Surgery Center Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093449225 PECOS PAC ID: 4880060888 Enrollment ID: O20221017001110 |
News Archive
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
On Monday (Jan. 25, 2016), the World Health Organization announced that Zika virus, a mosquito-borne illness that in the past year has swept quickly throughout equatorial countries, is expected to spread across the Americas and into the United States.
Five years on from September 11, the University of Western Sydney can offer expert comment on how the anniversary is likely to affect those who lost loved ones in the tragedy and how it will impact on people around the world.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd A Phillips, MD 804 Scott Nixon Memorial Dr, Augusta, GA 30907-2464 Ph: (800) 394-4445 | Todd A Phillips, MD 1615 Delaware St, Anesthesia Dept, Longview, WA 98632-2310 Ph: (360) 425-7280 |
News Archive
A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
On Monday (Jan. 25, 2016), the World Health Organization announced that Zika virus, a mosquito-borne illness that in the past year has swept quickly throughout equatorial countries, is expected to spread across the Americas and into the United States.
Five years on from September 11, the University of Western Sydney can offer expert comment on how the anniversary is likely to affect those who lost loved ones in the tragedy and how it will impact on people around the world.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 8 days ago
Bradford W Burger, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1516 Delaware St, Anesthesia Dept., Longview, WA 98632 Phone: 360-425-7280 | |
Bonnie Song, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 888-423-7717 | |
Herbert W Fleege, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Anesthesia Dept., Longview, WA 98632 Phone: 360-425-7280 | |
Stephanie L Davis, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2000 Fax: 360-414-7555 | |
Dr. Brian H Ngo, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-636-4878 Fax: 360-414-7638 | |
Dr. Chester Chi Tak Hu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Anesthesiology, Longview, WA 98632 Phone: 360-636-4878 Fax: 360-414-7457 |